Live Breaking News & Updates on Basement Membranes|Page 1

Search jobs
17-Dec-2020
Recombinant Human Endostatin Market Structure by Size, Valuable Shares, Industry Research, Top Manufacturers, Demand & Forecast Till 2026
Endostatin, a protein, is located in most Basement Membranes (BMs) in the body such as vascular basement membranes. Several research have reported the significant survival benefits of recombinant human endostatin in the treatment of late stage Non-Small-Cell Lung Carcinoma (NSCLC). In September 2005, the State Food and Drug Administration of China (CFDA) approved recombinant human endostatin (Endostar) for the treatment of NSCLC. Endostatin is expressed in various organs, with the highest levels in liver, lung, and kidney.
Recombinant Human Endostatin Market Drivers ....

United States , United Kingdom , Asia Pacific , Yantai Medgenn Ltd , Pfizer Inc , Intas Pharmaceuticals Ltd , Co Ltd , Centers For Disease , National Center , Genexine Inc , Peprotech Inc , Family Planning Commission , Chinese National Health , Browse Research Report , Drug Administration Of China , Yun Fei Xia University , Onyx Pharmaceuticals Inc , Basement Membranes , Non Small Cell Lung Carcinoma , State Food , Drug Administration , Biotechnology Information , Angioimmunoblastict Cell Lymphoma , Peripheralt Cell Lymphoma , Many Research , Promo Code ,